Ginkgo Bioworks Holdings (DNA) Debt Ratio (2020 - 2021)
Ginkgo Bioworks Holdings' (DNA) quarterly Debt Ratio came in at 0.0 in Q2 2021, down 17.64% quarter-over-quarter from 0.0 in Q4 2020.
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Debt Ratio (2020 - 2021) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Debt Ratio for 2 consecutive years, with 0.0 the latest figure, recorded in Q2 2021.
- For the quarter ending Q2 2021, Debt Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Jun 2021 stood at 0.0 (changed N/A YoY), and the FY2020 full-year result was 0.0, changed N/A from the prior year.
- Debt Ratio eased to 0.0 in Q2 2021 per DNA's latest filing, from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.0 in Q4 2020 and bottomed at 0.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 0.54 |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 0.35 |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 0.21 |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 0.39 |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 0.30 |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |